EXACT Sciences Corporation (EXAS)

Currency in USD
43.15
-3.76(-8.02%)
Closed·
After Hours
43.160.00(0.00%)
·
EXAS Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
Unusual trading volume
Trading near 52-week Low
EXAS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.8843.51
52 wk Range
38.8872.83
Key Statistics
Prev. Close
46.91
Open
39
Day's Range
38.88-43.51
52 wk Range
38.88-72.83
Volume
16.7M
Average Volume (3m)
2.79M
1-Year Change
-16.17%
Book Value / Share
12.9
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXAS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
68.55
Upside
+58.87%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

EXACT Sciences Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

EXACT Sciences Corporation Company Profile

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

EXACT Sciences Corporation Earnings Call Summary for Q2/2025

  • Exact Sciences Q2 2025 EPS of -$0.01 beat forecasts by 92.31%, revenue of $811.1M exceeded expectations by 4.82%
  • Revenue grew 16% year-over-year, with screening revenue up 18% and precision oncology revenue up 9%
  • Full-year revenue guidance raised to $3.130B-$3.170B, adjusted EBITDA guidance increased to $455M-$475M
  • Stock closed at $46.91, down 0.95% despite positive results; analysts maintain strong buy consensus with $54-$90 target range
  • CEO highlights transformation in cancer detection; CFO emphasizes strategic importance of recent acquisitions for long-term growth
Last Updated: 07/08/2025, 09:18
Read Full Transcript

Compare EXAS to Peers and Sector

Metrics to compare
EXAS
Peers
Sector
Relationship
P/E Ratio
−8.8x−3.2x−0.5x
PEG Ratio
0.02−0.160.00
Price/Book
3.6x2.4x2.6x
Price / LTM Sales
3.0x9.7x3.3x
Upside (Analyst Target)
43.9%576.4%43.5%
Fair Value Upside
Unlock−0.3%6.9%Unlock

Analyst Ratings

22 Buy
3 Hold
0 Sell
Ratings:
25 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 68.55
(+58.87% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-0.01 / -0.13
Revenue / Forecast
811.10M / 773.80M
EPS Revisions
Last 90 days

EXAS Income Statement

People Also Watch

152.97
CRCL
-5.40%
121.08
CRWV
+9.83%
50.43
GH
+13.10%
58.74
TEM
+5.78%
79.41
OKLO
-4.44%

FAQ

What Stock Exchange Does EXACT Sciences Trade On?

EXACT Sciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for EXACT Sciences?

The stock symbol for EXACT Sciences is "EXAS."

What Is the EXACT Sciences Market Cap?

As of today, EXACT Sciences market cap is 8.18B.

What Is EXACT Sciences's Earnings Per Share (TTM)?

The EXACT Sciences EPS (TTM) is -5.50.

When Is the Next EXACT Sciences Earnings Date?

EXACT Sciences will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is EXAS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has EXACT Sciences Stock Split?

EXACT Sciences has split 0 times.

How Many Employees Does EXACT Sciences Have?

EXACT Sciences has 6950 employees.

What is the current trading status of EXACT Sciences (EXAS)?

As of 07 Aug 2025, EXACT Sciences (EXAS) is trading at a price of 43.15, with a previous close of 46.91. The stock has fluctuated within a day range of 38.88 to 43.51, while its 52-week range spans from 38.88 to 72.83.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.